Beryl Ampong

The effects of MyD88 deficiency on disease phenotype in dysferlin‐deficient A/J mice: role of endogenous TLR ligands

E. Hoffman, K. Uaesoontrachoon, K. Nagaraju, 2013, The Journal of pathology.

Inhibition of inflammation with celastrol fails to improve muscle function in dysferlin-deficient A/J mice

C. Spurney, K. Nagaraju, E. Gallardo, 2015, Journal of the Neurological Sciences.

The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy.

G. S. Pandey, R. Wortmann, K. Nagaraju, 2012, Arthritis and rheumatism.

Recombinant adeno-associated virus type 8-mediated extensive therapeutic gene delivery into skeletal muscle of alpha-sarcoglycan-deficient mice.

S. Takeda, H. Nakai, Jin-Hong Shin, 2008, Human gene therapy.

Intracellular localization of dysferlin and its association with the dihydropyridine receptor.

S. Takeda, Mikiharu Yoshida, M. Imamura, 2005, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.

E. Hoffman, K. Nagaraju, Tatiana V Cohen, 2010, The American journal of pathology.

Role of Toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscle.

S. Agrawal, K. Nagaraju, H. Cha, 2014, Human molecular genetics.

Effect of hypothyroidism on beta-adrenoceptor-mediated relaxation in the rat thoracic aortae. A time-dependent study.

H. Kogo, Beryl Ampong, H. Honda, 2002, Vascular pharmacology.

Molecular Pathogenesis of Genetic and Inherited Diseases Inflammasome Up-Regulation and Activation in Dysferlin-Deficient Skeletal Muscle

E. Hoffman, K. Nagaraju, A. Henriques-Pons, 2010 .

The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy.

R. Wortmann, K. Nagaraju, R. Sabina, 2012, Arthritis and rheumatism.